Allozyne, Inc.
Records under this name other than the patents Allozyne, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 8 of 8 · Back to Allozyne, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,253,345 | Cell Lines Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,131,920 | Nucleic acid molecules Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,981,908 | Amino acid derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,670,521 | Amino acid derivatives Formerly held Lapsed on the fee record Ended Jun 6, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 6, 2025 | From the USPTO record |
| US 10,214,761 | Amino acid derivatives Formerly held Lapsed on the fee record Ended Feb 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 26, 2023 | From the USPTO record |
| US 10,202,447 | Antibody derivatives Lapsed on the fee record Ended Feb 12, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 12, 2023 | From the USPTO record |
| US 7,632,492 | Modified Human Interferon-Beta Polypeptides Lapsed on the fee record Ended Dec 15, 2021 · High confidence | Lapsed on the fee record | Ended Dec 15, 2021 | High confidence |
| US 8,568,706 | Modified Human Interferon-Beta Polypeptides Lapsed on the fee record Ended Oct 29, 2021 · Medium confidence | Lapsed on the fee record | Ended Oct 29, 2021 | Medium confidence |